NCT04239092 2025-07-179-ING-41 in Pediatric Patients With Refractory Malignancies.Actuate Therapeutics Inc.Phase 1 Terminated40 enrolled
NCT02507232 2020-07-28Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade GliomasSaint John's Cancer InstitutePhase EARLY_PHASE1 Terminated2 enrolled
NCT00960063 2018-08-27A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)Merck Sharp & Dohme LLCPhase 1 Terminated4 enrolled 8 charts